News Bliss GVS Pharma Limited

Equities

BLISSGVS

INE416D01022

Market Closed - Bombay S.E. Other stock markets 06:00:48 2024-05-17 am EDT			5-day change	1st Jan Change
109.6 ^INR	+0.37%		-0.72%	-12.08%

May. 02	Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
May. 02	Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 02	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 02	CI
Bliss GVS Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	May. 02	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 23	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 01	CI
Assistant Commission of State Tax Maharashtra, Mumbai Initiates Search At Certain Premises of Bliss GVS Pharma Limited	23-09-07	CI
Bliss Gvs Pharma Limited Announces Change in the Designation of Mr. Vishal Vijay Rao	23-08-01	CI
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-01	CI
Bliss GVS Pharma Limited Declares Final Dividend for the Financial Year Ended March 31, 2023	23-07-19	CI
Ex-dividend day for final dividend	23-07-11	FA
Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit	23-06-15	MT
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	23-05-11	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-11	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-11	CI
Infomerics Keeps BBB Rating on Bliss GVS Pharma's Bank Financing; Outlook Stable	23-04-10	MT
Bliss GVS Pharma Gets Three Observations from US FDA's Plant Inspection in Maharashtra, India	23-03-20	MT
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-24	CI
Bliss GVS Pharma Names New CFO	22-12-30	MT
Bliss GVS Pharma Limited Appoints Mr. Deepak Sawant as Chief Financial Officer	22-12-30	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bliss GVS Pharma Limited

Equities

BLISSGVS

INE416D01022

Summary

Filters